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Effectiveness of diabetes mellitus management program 
at primary health care level 
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ABSTRACT 
Annotation: Diabetes mellitus is considered not only a serious chronic disease, but also as an important medical and social problem that is becoming 
increasingly important. Disease management programs are needed to empower patients and help them develop the necessary skills for self-
management of their condition. 
Objective: To evaluate the effectiveness of the Type 2 Diabetes Management Program at the primary health care level. 
Methods: Study design is a prospective study, case-control. The study of the intervention group included 114 adults with type 2 diabetes participating 
in the Disease Management Program and the control group - 60 adults with type 2 diabetes not participating in the Disease Management Program. 
All the investigated persons live in the service area of the municipal polyclinic No. 4 of Aktobe city (Aktobe region, Western region of Kazakhstan). A 
traditional care which included regular follow-ups every 3 months was provided in the control group. The selection of patients in the control group 
was carried out by random sampling. Both groups were randomized by age, gender, and duration of illness. The main result evaluated glycated 
hemoglobin levels, blood pressure, body mass index, and low density lipoprotein levels after 9 months. 
Results: According to the data obtained after 9 months of the study the analysis showed a decrease in the average level of glycated hemoglobin in 
the intervention group (7.8 ± 1.5%) compared with the control group (8.6 ± 1.8%) (p <0.05). And also in the intervention group (134.6 ± 12.5 and 83.3 
± 6.5) compared with the control group (125.7 ± 10.4 and 80.7 ± 6.2), systolic and diastolic blood pressure is shown below. There were no statistically 
significant differences between the groups according to body mass index and low-density lipoprotein. 
Findings: This Diabetes Management Program allows you to control such indicators as glycated hemoglobin and blood pressure in a positive direction. 
While both body mass index and low density lipoproteins remained at the same level due to the short observation time. 
 
Keywords: diabetes, self-management, disease management program 
 
INTRODUCTION 
Diabetes mellitus is an important medical and social problem in the world and the Republic of Kazakhstan due to the 
widespread prevalence and steady growth of the incidence rate (1). In Kazakhstan, according to the National Register 
for 2018, 326,449 patients with this diagnosis were registered. Over 10 years the number of people suffering from 
diabetes in our country has more than doubled (18). According to WHO (World Health Organization) data in 2017 422 
million or 8.5% of the world’s adult population aged 18 years and over live with diabetes (18). According to the 
International Diabetes Federation (IDF) in 2017, 425 million (8.8%) of the adult population in the world suffer from type 
2 diabetes. About 80% of diabetic patients live in low- and middle-income countries (7,14). About 4 million people die 
of diabetes every year in the world, every 10 seconds 1 person dies from a diabetes-related disease. At present, diabetes 
mellitus takes the third place due to death among chronic noncommunicable diseases (19). And today diabetes remains 
one of the most urgent problems of modern health care, being the leading causes of high premature mortality and 
disability in developed countries. 
The goal of the Disease Management Program is to change the mentality of medical workers and a patient, create 
partnerships, involve patients in managing their personal health with the creation of a patient-oriented model to improve 
the health and quality of life of patients, reduce clinical complications, mortality and disability in chronic non-
communicable diseases (4,17). Few data available in Kazakhstan indicate favorable outcomes of this program, but they 
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have not yet been evaluated using prospective studies and have not been compared with traditional treatment. And this 
served as the basis for conducting studies to evaluate the effectiveness of the disease management program in our 
conditions. 
The purpose of this study was to evaluate the effectiveness of the Type 2 Diabetes Management Program compared 
to traditional care at the primary health care level. 
METHODS 
Study Design - Prospective Study, Case-Control 
The study was conducted in the conditions of the municipal polyclinic №4 of Aktobe city (Aktobe region, Western 
region of Kazakhstan). This is a prospective case-control study in primary care with randomization at the practice level. 
The groups were divided into the main groups (Diabetes Management Program) and the control group (traditional care). 
The main criteria for inclusion in the study were patients over the age of 18 and with type 2 diabetes mellitus, exclusion 
criteria were children and adolescents and patients with type 1 diabetes mellitus. All participants signed an informed 
consent. The study in the intervention group included 114 adults with type 2 diabetes participating in the Disease 
Management Program and in the control group there were 60 adults with type 2 diabetes not participating in the Disease 
Management Program. The selection of patients in the control group was carried out by random sampling. Both groups 
are randomized by age, gender, and duration of illness. The main result evaluated glycated hemoglobin levels, blood 
pressure, body mass index, and low density lipoprotein levels after 9 months. The studies were conducted on routine 
three-month appointments. This approach was used to minimize research costs and reduce the burden on patients. 
STATISTICAL ANALYSIS 
We used descriptive statistics. Continuous variables were expressed as mean and standard deviation; categorical 
variables were expressed as numbers and percentages. To evaluate the effectiveness of the program the data were 
analyzed and comparative statistics were made between the main parameters of the intervention group and the control 
group. To test the hypothesis of a normal distribution, the Shapiro-Wilk test was used. The marked criteria were 
significant at p <0.05. Statistical analysis and data processing was performed using software R v 3.5.1. 
RESULTS 
According to the results of the study the average age of patients with diabetes participating in the disease 
management program was 56.5 ± 8.1 years, and the average age of patients in the control group was 58 ± 8.8 years. Of 
the participants in the study group, men accounted for 49%, women 51%, and in the control group men - 45%, women 
 
Figure 1: Study design 
HbA1c: Glycated haemoglobin; BMI: body mass index; LDL: low density lipoproteins 
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- 55%. In the experimental group the duration of the disease with type 2 diabetes mellitus was 4.4 ± 3.5 years and in the 
control group it was 4.7 ± 3.3 years (Table 1). 
Both groups were the same in terms of age, gender, smoking status, and the use of sugar-lowering drugs (BSC, all 
drugs except insulin). There were no statistically significant differences between the groups (p <0.05). 
In patients with diabetes mellitus participating in the disease management program and not participating in the BMI 
program (body mass index) after 9 months it was 31 ± 5.1, in the control group 32 ± 4.7 (Table 2). There were no 
statistically significant differences between the groups according to BMI (body mass index) (p> 0.05) (Figure 2). 
The level of systolic blood pressure in patients with diabetes mellitus participating in the Disease Management 
Program after 9 months was 125.6 ± 10.4 mm Hg, in the control group not participating in the program - 134.6 ± 12.5 
mm Hg and in the intervention group diastolic blood pressure was 80.7 ± 6.2 mm Hg, while in the control group it was 
83.3 ± 6.5 mm Hg (Table 2). The level of systolic and diastolic pressure in patients with diabetes mellitus participating in 
the Disease Management Program was lower than in patients with diabetes mellitus not participating in the Disease 
Management Program. There are statistically significant differences between groups in blood pressure (p <0.05) 
(Figure 3). 


























Duration of illness  (years) 4.4±3.5 4.7±3.3 4.5±3.6 p >0.05 
The status of 
Smoking 
Smoke 


















Body mass index (kg/m²) 31±5.1 32±4.7 p >0.05 
Systolic blood pressure (mmHg) 125.7±10.4 134.6±12.5 p <0.05 
Diastolic blood pressure (mmHg) 80.7±6.2 83.3±6.5 p <0.05 
Low density lipoproteins (mg/dL) 3.5±1.1 3.7±0.9 p >0.05 
Glycated haemoglobin (HbA1C) (%) 7.8±1.5 8.6±1.8 p <0.05 
 
 
Figure 2: The level of BMI in the intervention group and the control group after 3, 6 and 9 months (kg / m²) 
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Glycated hemoglobin has been widely used in studies of diabetes mellitus (11), in particular, to assess the 
effectiveness of diabetes management (12,13,15). 
The study also analyzed laboratory analyzes of patients, the average levels of glycated hemoglobin (HbA1c) in the 
control group after 9 months was 8.6 ± 1.8%, in the intervention group 7.8 ± 1.5% (Table 2). The analysis showed a 
decrease in the average level of glycated hemoglobin in the intervention group compared with the control group after 
9 months (p <0.05). 
The average levels of LDL cholesterol (low density lipoproteins) in the intervention group 3.5 ± 1.1 mmol / L were 
higher than in the control group 3.7 ± 0.9 mmol / L (Table 2). There were no statistically significant differences between 
the groups according to LDL (low density lipoproteins) (p> 0.05) (Figure 4). 
There were no significant differences between the intervention group and the control group according to baseline 
characteristics after 3, 6 and 9 months. 
 




Figure 4: The level of low density liproteincholesterol (mg/dL) and glycated hemoglobin in the intervention group and the 
control group after 3, 6 and 9 months (%) 
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DISCUSSION 
One of the most promising directions in the prevention and treatment of patients with diabetes mellitus and in 
achieving control over the main manifestations of diseases is the training of patients in self-control and self-help skills 
(16). The self-government program is an important basic approach to empowering and necessary for patients to 
effectively manage their behavior, including controlling blood glucose levels, managing hyperglycemia and 
hypoglycemia symptoms, controlling diet and exercise management (5,6). However, mainly patients with diabetes have 
difficulty controlling their behavior (8). The self-government program is promoted in connection with positive results, 
especially in managing behavior and improving the quality of life among patients with type 2 diabetes (9). 
Our analysis of thereferences shows positive effects for groups of patients participating in the Disease Management 
Program in comparison with non-participating patients. Studies in the United States have shown that participating in a 
self-management program improves the outcomes of patients who have already received diabetes education (10). 
In Germany, a disease management program was introduced more than 10 years ago. The data from the German 
disease management program for type 2 diabetes mellitus demonstrate an improvement in the quality of treatment in 
relation to pharmacotherapy and patient education and, therefore, more stringent adherence to guidelines. However, 
no significant improvement was observed with respect to smoking status, obesity or control of HbA1c (glycated 
hemoglobin) (2). 
In India, the results of the study showed that the self-management education program is an important component 
in diabetes management and provided concrete evidence that it is an effective way of controlling body weight, blood 
pressure and glycated hemoglobin level in type 2 diabetes mellitus (3). 
Based on the results of our study we also studied the effectiveness of Type 2 Diabetes Management Program, 
compared to traditional conventional care at the primary health care level. This study is one of the first studies in 
Kazakhstan to evaluate the intervention carried out in primary health care facilities to improve health outcomes in a 
group of patients not participating in the Type 2 Diabetes Disease Management Program. After a 9-month follow-up in 
the intervention group for patients with type 2 diabetes mellitus, a decrease in glycated hemoglobin and blood pressure 
was observed compared with the control group. Type 2 diabetes management program has had a positive effect on 
changes in glycated hemoglobin and blood pressure. There were no statistically significant differences between the 
groups according to body mass index and low-density lipoproid. This also confirms the effectiveness of the program 
being studied. 
CONCLUSION 
This Diabetes Management Disease Management Program allows you to control for the study such indicators as 
glycated hemoglobin and blood pressure in a positive direction. When both the body mass index and low density 
lipoproteins remained at the same level due to the short observation time. 
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